METHOTREXATE ANALOGS AND METHODS OF USE Read more about METHOTREXATE ANALOGS AND METHODS OF USE Australia2021296308Filed on 2021-06-22
TAT PEPTIDE BINDING PROTEINS AND USES THEREOF Read more about TAT PEPTIDE BINDING PROTEINS AND USES THEREOF South Korea10-2022-7030361Filed on 2021-02-05
TAT PEPTIDE BINDING PROTEINS AND USES THEREOF Read more about TAT PEPTIDE BINDING PROTEINS AND USES THEREOF European Patent21709825.0Filed on 2021-02-05
SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF Read more about SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF European Patent20794764.9Filed on 2020-03-11
SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF Read more about SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF European Patent22162126.1Filed on 2016-11-23
TAT PEPTIDE BINDING PROTEINS AND USES THEREOF Read more about TAT PEPTIDE BINDING PROTEINS AND USES THEREOF India202217049798Filed on 2021-02-05
Deuterated Alpha5 Subunit-selective Negative Allosteric Modulators Of Gamma-Aminobutyric Acid Type A Receptors As Fast Acting Treatments For Depression And Mood Disorders Read more about Deuterated Alpha5 Subunit-selective Negative Allosteric Modulators Of Gamma-Aminobutyric Acid Type A Receptors As Fast Acting Treatments For Depression And Mood Disorders US Patent 11,897,875Filed on 2022-08-09
SYNTHETIC HUMANIZED LLAMA NANOBODY LIBRARY AND USE THEREOF TO IDENTIFY SARS-COV-2 NEUTRALIZING ANTIBODIES Read more about SYNTHETIC HUMANIZED LLAMA NANOBODY LIBRARY AND USE THEREOF TO IDENTIFY SARS-COV-2 NEUTRALIZING ANTIBODIES Patent Cooperation TreatyPCT/US2022/076221Filed on 2022-09-09
Small Molecule Inhibitors Of Lactate Dehydrogenase and Methods of Use Thereof Read more about Small Molecule Inhibitors Of Lactate Dehydrogenase and Methods of Use Thereof Hong Kong42022055599.9Filed on 2022-06-22
CRYSTAL FORMS AND METHODS OF SYNTHESIS OF (2R, 6R)-HYDROXYNORKETAMINE AND (2S, 6S)-HYDROXYNORKETAMINE Read more about CRYSTAL FORMS AND METHODS OF SYNTHESIS OF (2R, 6R)-HYDROXYNORKETAMINE AND (2S, 6S)-HYDROXYNORKETAMINE Japan2022-041167Filed on 2017-03-27